FDA (CDRH)
GUIDANCE FINAL
Medical Devices with Indications Associated with Weight Loss - Premarket Considerations: Guidance for Industry and Food and Drug Administration Staff
Published: 3/13/2026Detected: 3/25/2026
Summary preview
Clarifies FDA CDRH premarket considerations for medical devices whose indications are associated with weight loss, emphasizing how device claims should be supported by appropriate clinical and safety evidence.
Get the full analysis, free
Create a free account to see the complete summary, key takeaways, and why this matters for your products, and to get alerts like this by email.
Create free accountgastroenterology
cardiology
neurology
respiratory
pediatrics
#CDRH guidance
#premarket review
#weight loss indication
#medical devices
#clinical evidence
Official Source Document Source Verified
Access the original document directly from FDA CDRH.
More from FDA (CDRH)
- Robotically-Assisted Surgical Devices - Premarket Submissions: Draft Guidance for Industry and Food and Drug Administration Staff9/25/2026
- Electronic Submission Template for Premarket Approval Applications (PMA): Draft Guidance for Industry and Food and Drug Administration Staff9/18/2026
- Dental Curing Lights - Premarket Notification (510(k)) Submissions: Guidance for Industry and Food and Drug Administration Staff9/2/2026
- Dental Composite Resin Devices - Premarket Notification (510(k)) Submissions: Guidance for Industry and Food and Drug Administration Staff9/2/2026
- Applying Human Factors and Usability Engineering to Medical Devices: Guidance for Industry and Food and Drug Administration Staff8/3/2026